VIA
TRIL

Vident Investment Advisory’s Trillium Therapeutics Inc. TRIL Stock Holding History

Vident Investment Advisory’s Portfolio TRIL Stock Details TRIL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
2021
Q3 		$2.64M Sell
2021
Q2 		$1.56M Buy
2021
Q1 		$1.47M Buy
2020
Q4 		$2M Sell
2020
Q3 		$2.45M Sell
2020
Q2 		$1.43M Buy